NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces the filing of a shareholder class action lawsuit against GTx, Inc. (“GTx” or the “Company”) (GTXI) in connection with the proposed sale of GTx to Oncternal Therapeutics, Inc. (“Oncternal”).
If you are a GTx shareholder and would like to discuss your legal rights and options, please visit GTx (GTXI) Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or firstname.lastname@example.org or email@example.com.
The lawsuit alleges that Defendants issued a materially misleading registration statement recommending that GTx shareholders vote in favor of the proposed transaction. According to the complaint, the registration statement contains materially incomplete and/or misleading information concerning: (1) GTx’s and Oncternal’s financial projections relied upon by the Company’s financial advisor in support of its fairness opinion of the proposed transaction; and (2) potential conflicts of interests affecting certain members of the Board. As a result, GTx shareholders must be provided with this information in order to adequately assess and value the merger consideration. The lawsuit seeks to enjoin the shareholder vote on the proposed transaction until such information is disclosed.
If you are a GTx shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/gtx-inc-gtxi-merger-oncternal-stock/ or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or firstname.lastname@example.org or email@example.com.
Our attorneys represent investors all over the world who have fallen victim to securities fraud and corporate misconduct. They have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.